Global Therapeutic BCG Vaccines Market Segments 2024, Forecast To 2033
5 Mar, 2024
The therapeutic BCG vaccines market has shown strong growth, increasing from $53.99 billion in 2023 to $57.14 billion in 2024, with a 5.8% CAGR. Growth drivers include government initiatives for TB control and global immunization programs. The market is poised for strong growth, reaching $72.54 billion in 2028, reflecting a 6.1% CAGR. Trends include advancements in vaccine technology and market consolidation, with a focus on personalized medicine approaches.
Global Therapeutic BCG Vaccines Market Key Driver
The therapeutic BCG vaccine market is on the rise due to the increasing number of tuberculosis (TB) cases worldwide. In 2021, an estimated 10.6 million people contracted TB, representing a 4.5% increase from the previous year. The therapeutic BCG vaccine plays a crucial role in preventing and treating TB, contributing to market growth.
Get A Free Sample Of The Global Therapeutic BCG Vaccines Market ReportGlobal Therapeutic BCG Vaccines Market Segments
The therapeutic bcg vaccines market covered in this report is segmented –
1) By Type: Therapy BCG, Immune BCG
2) By Demographics: Pediatrics, Adults
3) By End Use: Hospitals, Clinics, Other End Users
By Geography: The regions covered in the anti inflammatory therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe,North America, South America, Middle East, and Africa. Among these regions.
Asia-Pacific was the largest region in the therapeutic BCG vaccines market in 2023. The regions covered in the therapeutic bcg vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Major Therapeutic BCG Vaccines Industry Players
Merck & Co Inc.; Sanofi Pasteur; Japan BCG Laboratory; China National Biotec Group; Serum Institute of India Pvt. Ltd.; InterVax Ltd.; GreenSignal Bio Pharma Limited; Statens Serum Institute; AJ Vaccines; Bul Bio-National Center of Infectious and Parasitic Diseases Ltd; Biomed Lublin S.A.; PowderJect Pharmaceuticals; Microgen; Taj Pharma Ltd.; PT Bio Farma; Torlak Institute of Virology; Bacille Bilie Calmette-Guerin Laboratory; China Biotechnology Co Ltd.; GlaxoSmithKline plc; Pfizer Inc.; Bharat Biotech International Ltd.; Biological E. Limited; Shanghai Institute of Biological Products Co. Ltd.; Immunitor; Vakzine Projekt Management GmbH; Cipla Limited; Instituto Butantan; Chiron Corporation
Get The Full Global Therapeutic BCG Vaccines Market ReportAIOps Therapeutic BCG Vaccines Market Overview
Therapeutic BCG vaccine refers to a vaccine that offers defense against TB, also referred to as tuberculosis. The therapeutic BCG vaccine, which stands for the Bacillus Calmette-Guérin vaccine, is not a part of the standard NHS vaccination schedule. Only one dose of the BCG vaccine should be administered in a lifetime.
Therapeutic BCG Vaccines Global Market Report 2023 provides data on the global therapeutic bcg vaccines market such as market size, growth forecasts, segments and geographies, competitive landscape including leading competitors’ revenues, profiles and market shares. The therapeutic bcg vaccines market report identifies opportunities and strategies based on market trends and leading competitors’ approaches.